(Q46956599)

English

Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study

scientific article published on 10 October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

1 reference

based on heuristic

inferred from title

author name string

Christoph Schindler

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

Axel Mueller

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

Peter Bramlage

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

Wolfgang Boecking

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

Wilhelm Kirch

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

Johannes Schweizer

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

publication date

10 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

58

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

710-716

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study.

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells.

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angio

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

Effects of candesartan and probucol on restenosis after coronary stenting: results of insight of stent intimal hyperplasia inhibition by new angiotensin II receptor antagonist (ISHIN) trial

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

Angiotensin-converting enzyme 2 is an essential regulator of heart function

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat.

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

1 reference

https://api.crossref.org/works/10.1177%2F0003319707305962

21 January 2018

Identifiers

10.1177/0003319707305962

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17928625

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46956599&oldid=2139668536"